Tweenvest Stocks

Kringle Pharma, Inc. (TSE: 4884)

Health Care · Biotechnology · JP

¥614.00

-4.81% today · +36.7% 1Y

Kringle Pharma, Inc. (TSE: 4884) operates in the Biotechnology industry within the Health Care sector. The company is valued at $32.60M and employs 17 people.

Over the last twelve months the share price has gained 36.7%, trading between 287.00 and 741.00.

Tweenvest scores Kringle Pharma, Inc. across four factors: quality 45/100, value 73/100, growth 0/100. Its strongest factor is value.

4884 price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$32.60M
Revenue (TTM)
$2.11M
P/E
—
EPS
-110.24
Dividend yield
—
Beta (5Y)
0.38
52-week high
¥741.00
52-week low
¥287.00
Avg volume (3M)
—
Shares outstanding
8.38M
Employees
17
Next earnings
—

About Kringle Pharma, Inc.

Kringle Pharma, Inc. specializes in the innovation, production, and distribution of hepatocyte growth factor (HGF) protein-based therapeutics aimed at regenerative medicine. The company's cutting-edge HGF solutions are designed to address serious medical conditions including acute spinal cord injury, amyotrophic lateral sclerosis, vocal fold scars, and acute kidney injury. Founded in 2001, Kringle Pharma operates from its base in Ibaraki, Japan.

ISIN
JP3270790003
Founded
2001
Listed since
Dec 28, 2020
Exchange
The Tokyo Stock Exchange
Currency
JPY
CompanyMarket capPriceDay
Mabion S.A.WSE: MAB$33.59Mzł8.07+0.88%
Genetics Generation Advancement Corp.TPEX: 4160$33.50MNT$38.80-0.26%
Vivoryon Therapeutics N.V.ENXTAM: VVY$32.98M€0.99-5.71%
QuantaMatrix Inc.KOSDAQ: A317690$32.77M₩2,170.00-6.26%
Quince Therapeutics, Inc.NasdaqGS: QNCX$32.58M$32.03+0.95%
GeneBioTech Co. ,LtdKOSDAQ: A086060$32.23M₩4,990.00-1.58%
Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S.IBSE: ANGEN$31.63MTL7.12-13.59%
GeneOne Life Science, Inc.KOSE: A011000$31.40M₩——

Browse every Biotechnology company →

Figures last refreshed Oct 18, 2026.